Key result
Transcatheter aortic valve implantation is a suitable alternative to surgery in high-risk patients and provides a clear mortality benefit over medical treatment in inoperable patients.
Why the study?
Transcatheter aortic valve implantation (TAVI) has rapidly evolved with expanding indications and outcomes, but controversies and future directions remain to be summarized.
Answers are grounded in this paper and cite their sources.
During the last decade, transcatheter aortic valve implantation (TAVI) has become a revolution in the treatment of high-risk severe aortic stenosis (AS). Current guidelines provide a Class I indication for TAVI in inoperable AS and Class IIa indication for TAVI as an alternative to surgical repair in high-risk patients. A large amount of retrospective, prospective, and randomised data has been published covering almost every angle of the procedure. Improved patient evaluation and selection, new devices, and technical refinements will reduce procedural complications and improve long-term outcomes. With a growing elderly population segment in the Western countries, the procedure has a bright perspective. The purpose of this review is to summarise the state of the art of TAVI procedures, including current indications, and describe procedural characteristics, as well as short and long-term outcomes. Controversial issues such as paravalvular regurgitation and stroke are discussed, as well as off-label indications. A shift towards intermediate risk AS patients, approval of some of the off-label indications, and device versus device competition are some of the future directions of the technique.
No takes yet. Share an insight, caveat, or question.
Salinas et al. (2015) conducted a review in Severe aortic stenosis. Transcatheter aortic valve implantation (TAVI) vs. Surgical aortic valve replacement (SAVR) or medical treatment was evaluated. Transcatheter aortic valve implantation is a suitable alternative to surgery in high-risk patients and provides a clear mortality benefit over medical treatment in inoperable patients.
Synapse has enriched 10 related papers. Consider them for comparative context: